Cure My Disease

Don't miss your cure!

 Log in / Sign up

New training program aims to help people with ultra low vision see and live better

NCT ID NCT05028712

Recruiting now Symptom relief Sponsor: State University of New York College of Optometry Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a multi-sensory rehabilitation program for people with ultra low vision (visual acuity of 20/1600 or worse). The program includes training to use remaining vision better and to combine input from different senses. Researchers hope this will improve daily function and quality of life. The study involves 36 participants and is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral training (visual information training and multimodal training)
What this could lead to
If it works, this could point toward a better rehabilitation program to help people with very low vision function more independently and improve their quality of life.
What could go wrong
This is a small, early-stage study with only 36 participants, so results may not apply to everyone. The training is behavioral, so benefits may vary and are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL VISUAL LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

blindness (disorder) vision disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FUNCTIONAL VISUAL LOSS LOW VISION BLINDNESS QUALITY OF LIFE VISUAL IMPAIRMENT

Contacts and locations

Locations

  • SUNY College of Optometry

    RECRUITING

    New York, New York, 10036, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.